Here are 10 key notes:
1. The company’s total reported revenue was $59.2 million for the second quarter of 2016, up 5.1 percent compared to the same period the year prior.
2. Total revenue increased 5.3 percent year-over-year on a constant currency basis.
3. K2M suffered a net loss of $11.1 million in the second quarter, as compared to a loss of $6.2 million during the same period last year.
4. Revenue in the United States increased 9.2 percent from the second quarter in 2015 to $45.2 million.
5. U.S. revenue for K2M’s complex spine category grew 8.2 percent; minimally invasive surgery category grew 15.9 percent and degenerative category grew 7.9 percent.
6. International revenue decreased $0.9 million to $14 million in the second quarter of this year.
7. Operating expenses for second quarter 2016 increased by 5.5 percent from the same period last year to $48.9 million.
8. Loss from operations for the second quarter was $9.3 million, compared to an $8.6 million loss from operations last in the second quarter of 2015.
9. Gross profit for second quarter of 2016 increased to $39.6 million, compared to $37.7 million for second quarter of 2015.
10. The company received FDA clearance for a number of products in the second quarter, including the CASCADIA Cervical and the CASCADIA AN Lordotic Oblique Interbody Systems.
More articles on devices:
Corin Group, FX Solutions sign distribution agreement for US market: 4 points
Amendia plans to expand manufacturing facility expansion: 5 things to know
Vertical Spine’s FIBRINET System reaches 1k cases milestone: 4 notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
